heads.gr valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | Heads - Global Hemato-Oncology |
| Description | Ingenuity meets Health Data Specialists, “HeaDS” is a full-service European Contract Research Organization (CRO) dedicated to the conduct of clinical |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 87.239.19.80 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
heads.gr Valuation
|
US$2,388
Last updated: 2023-05-15 16:28:41
heads.gr has Semrush global rank of 0. heads.gr has an estimated worth of US$ 2,388, based on its estimated Ads revenue. heads.gr receives approximately 275 unique visitors each day. Its web server is located in United Kingdom, with IP address 87.239.19.80. According to SiteAdvisor, heads.gr is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,388 |
| Daily Ads Revenue | US$2 |
| Monthly Ads Revenue | US$66 |
| Yearly Ads Revenue | US$793 |
| Daily Unique Visitors | 18 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| heads.gr. | A | 86399 | IP: 87.239.19.80 |
| heads.gr. | NS | 86400 | NS Record: ns2.headsprod.uk.plesk-server.com. |
| heads.gr. | NS | 86400 | NS Record: ns1.headsprod.uk.plesk-server.com. |
| heads.gr. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.COM. |
| heads.gr. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.COM. |
| heads.gr. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.COM. |
| heads.gr. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.COM. |
| heads.gr. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.COM. |
HtmlToTextCheckTime:2023-05-15 16:28:41
| SUBMIT RFP SUBMIT RFP Ingenuity meets passion. A global * CRO specialized in hemato-oncology. At Heads, scientific and technical expertise meet hunger for excellence; every single day. * Offices in North America, Europe, Asia-Pacific About us About us Services Bringing hope to each patient is our strongest driver Clinical Operations More More Pharmacovigilance More More Medical Affairs More More Regulatory More More Biometrics More More Quality Assurance More More Design and run your Clinical Study Practical guidance to those beginning the challenging and rewarding journey in clinical research. Get started Get started Notable Studies EAE120 Multiple Myeloma A Phase 1/2 study of belantamab mafodotin administered in combination with daratumumab, lenalidomide and dexamethasone in patients with newly diagnosed MM not eligible for ASCT. EAE127 Multiple Myeloma A Phase 1/2 study of belantamab mafodotin administered in combination with daratumumab, pomalidomide, and dexamethasone in |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 05 Jan 2022 08:41:44 GMT Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Location: http://heads-research.com/ X-Powered-By: PleskLin HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 05 Jan 2022 08:41:45 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://heads-research.com/ HTTP/2 200 server: nginx date: Wed, 05 Jan 2022 08:41:45 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.3.33 x-powered-by: PleskLin |